These targets are enriched in multiple pathways related to type 2 diabetes mellitus, including adipocytokine, AMPK, TNF, HIF-1, PI3K-AKT, NOD and TOLL-like receptors, mTOR, glucagon, and insulin signaling pathways. The gene discussed is AKT1; the disease is type 2 diabetes mellitus.